Stock DNLI DENALI THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Denali Therapeutics Inc.

Equities

DNLI

US24823R1059

Market Closed - Nasdaq
Other stock markets
 01:30:00 27/04/2024 am IST 		5-day change 1st Jan Change
15.43 USD +3.14% Intraday chart for Denali Therapeutics Inc. -3.56% -28.10%
09/04 UBS Adjusts Denali Therapeutics Price Target to $32 From $70, Maintains Buy Rating MT
03/04 Denali Therapeutics Insider Sold Shares Worth $1,896,250, According to a Recent SEC Filing MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. DNLI Stock
  4. Revisions Denali Therapeutics Inc.